documents: FDA-2022-E-2095-0003
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2022-E-2095-0003 | FDA | FDA-2022-E-2095 | Letter to U S Patent and Trademark Office from FDA CDER | Other | Correspondence | 2022-09-13T04:00:00Z | 2022 | 9 | 2022-09-13T04:00:00Z | 2022-09-13T15:24:53Z | 0 | 0 | 09000064852f7ec7 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref